Skip to main content
OpenTrials
Completed

NCT Number: NCT06895382

Caudal Epidural Vs. TAP Block for Postoperative Analgesia in Pediatric Infraumbilical Surgery: a RCT

This randomized controlled trial investigates the postoperative analgesic efficacy of caudal epidural block versus ultrasound-guided transversus abdominis plane (TAP) block in pediatric patients undergoing infraumbilical surgery.

A total of 60 pediatric patients (aged 1 to 7 years, ASA I-II) were randomly assigned to one of two groups:

* Group C (Caudal Block): Received 1 mL/kg of 0.25% bupivacaine in the caudal epidural space. * Group T (TAP Block): Received 0.3 mL/kg of 0.25% bupivacaine injected into the transversus abdominis plane under ultrasound guidance.

Primary Outcome:

* Postoperative FLACC pain scores at 2, 6, 12, and 24 hours.

Secondary Outcomes:

* Total analgesic consumption (including rescue analgesia). * Intraoperative hemodynamic parameters (heart rate, blood pressure, SpO₂). * Incidence of nausea and vomiting (PONV). * Parental satisfaction scores.

The study aims to determine which regional anesthesia technique provides superior pain relief and reduces systemic analgesic requirements in pediatric patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 year–7 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tekirdag Namik Kemal University

Tekirdağ, Turkey (Türkiye)

About this study

Postoperative pain management in pediatric patients is a challenge due to difficulties in pain assessment and concerns about opioid-related adverse effects. While caudal epidural block has traditionally been the standard of care for infraumbilical pediatric surgeries, ultrasound-guided transversus abdominis plane (TAP) block has emerged as a promising alternative with the potential for longer-lasting analgesia and fewer motor block complications.

This randomized controlled trial was conducted at Tekirdağ Namık Kemal University Hospital between December 2022 and December 2023. A total of 60 pediatric patients (aged 1-7 years, ASA I-II) undergoing infraumbilical surgery were enrolled and randomly assigned to receive either:

  • Caudal epidural block (1 mL/kg of 0.25% bupivacaine via the sacral hiatus).
  • TAP block (0.3 mL/kg of 0.25% bupivacaine in the fascial plane between the internal oblique and transversus abdominis muscles under ultrasound guidance).

General anesthesia was induced using sevoflurane inhalation, followed by propofol (2-3 mg/kg) and fentanyl (1 µg/kg) for IV induction. A laryngeal mask airway (LMA) was used, and anesthesia was maintained with sevoflurane at a MAC of 1.0%.

Outcome Measures:

  • Primary Outcome:
  • FLACC pain scores at 2, 6, 12, and 24 hours postoperatively.
  • Secondary Outcomes:
  • Total postoperative analgesic consumption (including rescue analgesia).
  • Hemodynamic parameters (HR, SBP, DBP, SpO₂) recorded at predefined intraoperative time points.
  • Incidence of postoperative nausea and vomiting (PONV).
  • Parental satisfaction scores collected post-discharge.

Statistical Analysis:

Data were analyzed using SPSS 25.0. Sample size was determined using G*Power 3.1.9.2, with an effect size (d) of 0.75, power of 0.80, and Type I error of 0.05. The study followed randomized allocation with blinding of pain assessors.

This study aims to determine whether TAP block provides equivalent or superior analgesia compared to caudal epidural block in pediatric patients undergoing infraumbilical surgeries. Findings will help guide future pediatric regional anesthesia protocols.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pediatric patients aged 1 to 7 years.
  • ASA Physical Status I-II.
  • Undergoing infraumbilical abdominal surgery (e.g., hernia repair, orchiopexy, circumcision).
  • Parental written informed consent obtained.

Exclusion criteria

  • Contraindications to regional anesthesia, such as:
  • Coagulopathy or bleeding disorders.
  • Local infection at the injection site.
  • Known allergy to local anesthetics.
  • Neurological conditions (e.g., degenerative neuropathy, brain tumors, increased intracranial pressure).
  • Intellectual disabilities affecting pain assessment.
  • Chronic pain conditions or opioid use before surgery.
  • Parental refusal to participate in the study.

Treatment and study plan

Caudal Epidural Block

Procedure

A caudal epidural block was performed after the induction of general anesthesia. Using a 35-mm 22G or 30-mm 25G block needle, the sacral hiatus was identified, and the needle was inserted through the sacrococcygeal ligament into the epidural space under aseptic conditions. After confirming negative aspiration for cerebrospinal fluid or blood, 1 mL/kg of 0.25% bupivacaine was administered.

Other names: Caudal Block, Caudal Anesthesia

Transversus abdominis plane (TAP) block

Procedure

A transversus abdominis plane (TAP) block was performed after the induction of general anesthesia. Using a 22G, 50-mm insulated block needle, the injection was administered under ultrasound guidance using a linear probe and in-plane technique. The needle was advanced into the fascial plane between the internal oblique and transversus abdominis muscles. After confirming placement with a 0.5-1 mL test dose of 0.9% NaCl and negative aspiration for blood, 0.3 mL/kg of 0.25% bupivacaine was administered.

Other names: TAP Block, Ultrasound-Guided TAP Block

Bupivacaine 0.25%

Drug

0.25% bupivacaine was administered in both intervention arms as part of the regional anesthesia procedure In the Caudal Block group, 1 mL/kg of 0.25% bupivacaine was administered into the caudal epidural space.

In the TAP Block group, 0.3 mL/kg of 0.25% bupivacaine was administered into the transversus abdominis plane under ultrasound guidance

Primary outcomes

  1. Postoperative FLACC Pain Scores

    Time frame: FLACC pain scores were recorded at 2, 6, 12, and 24 hours postoperatively

    Postoperative pain intensity was measured using the Face, Legs, Activity, Cry, Consolability (FLACC) scale at predefined time points after surgery. The FLACC scale is a validated tool for assessing postoperative pain in pediatric patients based on behavioral observations.

Secondary outcomes

  1. Total Postoperative Analgesic Consumption

    Time frame: 0-24 hours postoperatively

    The total amount of rescue analgesia (paracetamol, NSAIDs, opioids) administered in the first 24 hours postoperatively was recorded. This includes any additional medication given based on the patient's pain score.

  2. Intraoperative Hemodynamic Stability

    Time frame: Baseline, after induction, after surgical incision, and at 15, 30, 45, and 60 minutes intraoperatively.

    Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and arterial oxygen saturation (SpO₂) were recorded at predefined intraoperative time points to assess the hemodynamic effects of the regional anesthesia techniques.

  3. Incidence of Postoperative Nausea and Vomiting (PONV)

    Time frame: 0-24 hours postoperatively

    The number of patients experiencing postoperative nausea and vomiting (PONV) within the first 24 hours was recorded.

  4. Parental Satisfaction Scores

    Time frame: Recorded at 24 hours postoperatively and at a follow-up phone call after discharge.

    Parental satisfaction with their child's postoperative pain management was assessed using a 5-point Likert scale, ranging from 1 (very dissatisfied) to 5 (very satisfied).

Sponsors and collaborators

Lead sponsor

Namik Kemal University

Other

Registry information

Official study title

Comparison of Caudal Epidural Block and Ultrasound-Guided Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia in Pediatric Infraumbilical Surgery: a Randomized Controlled Trial

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Mar 26, 2025
Registry last updated
Apr 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.